Audiomedica.com
Palbociclib Combination Prolongs Life After Breast Cancer Hormone Therapy
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:00:07
- Mas informaciones
Informações:
Sinopsis
MUNICH—Patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer who were treated with a combination of the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib in combination with fulvestrantlived longer than those receiving a placebo …Massimo Cristofanilli AJO PRODUCTION MASTER
